China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.470 HKD | -2.19% |
|
+5.42% | +0.45% |
| 29/06 | China Resources Pharmaceutical Unit Sells 2 Billion Yuan Bonds | MT |
| 01/06 | China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3% | MT |
| Market Cap | 2.87TCr 366.09Cr 320.62Cr 295.31Cr 274.12Cr 520.54Cr 35TCr 527.58Cr 3.54TCr 1.38TCr 17TCr 1.37TCr 1.34TCr 59TCr | P/E 2026 * |
5.83x | P/E 2027 * | 5.45x |
|---|---|---|---|---|---|
| Enterprise Value | 8.21TCr 1.05TCr 916.42Cr 844.08Cr 783.49Cr 1.49TCr 1LCr 1.51TCr 10TCr 3.93TCr 49TCr 3.93TCr 3.84TCr 1,69900Cr | EV / Sales 2026 * |
0.25x | EV / Sales 2027 * | 0.22x |
| Free-Float |
28.62% | Yield 2026 * |
4.49% | Yield 2027 * | 4.9% |
| 1 day | -2.19% | ||
| 1 week | +5.42% | ||
| Current month | +5.42% | ||
| 1 month | -5.89% | ||
| 3 months | -27.67% | ||
| 6 months | -3.25% | ||
| Current year | +0.45% |
| 1 week | 4.31 |  | 4.61 |
| 1 month | 4.22 | | 4.98 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 54 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/20/01 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/20/31 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.19% | +5.42% | -14.20% | -28.25% | 360.45Cr | |
| -1.14% | -2.43% | +53.72% | +159.07% | 1,08200Cr | |
| -1.41% | +0.32% | +66.23% | +60.48% | 63TCr | |
| -2.42% | +0.18% | +34.59% | +85.62% | 46TCr | |
| -0.26% | +0.53% | +31.00% | +25.82% | 34TCr | |
| -2.46% | -1.38% | +36.42% | +36.52% | 30TCr | |
| -2.20% | -0.87% | +27.50% | +42.69% | 29TCr | |
| -1.77% | +1.97% | -28.85% | -40.66% | 22TCr | |
| -2.06% | +1.63% | +22.87% | +64.34% | 20TCr | |
| -1.26% | +2.60% | +15.98% | +70.00% | 16TCr | |
| Average | -1.72% | +1.00% | +24.53% | +47.56% | 36.96TCr | |
| Weighted average by Cap. | -1.55% | -0.22% | +39.56% | +80.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 32TCr 4.14TCr 3.63TCr 3.34TCr 3.1TCr 5.89TCr 3,94900Cr 5.97TCr 40TCr 16TCr 1,93900Cr 16TCr 15TCr 6,72100Cr | 34TCr 4.35TCr 3.81TCr 3.51TCr 3.26TCr 6.19TCr 4,15200Cr 6.27TCr 42TCr 16TCr 2,03800Cr 16TCr 16TCr 7,06600Cr |
| Net income | 482.57Cr 62Cr 54Cr 50Cr 46Cr 87Cr 5.87TCr 89Cr 594.15Cr 231.23Cr 2.88TCr 231.08Cr 226.01Cr 9.99TCr | 522.18Cr 67Cr 58Cr 54Cr 50Cr 95Cr 6.35TCr 96Cr 642.93Cr 250.21Cr 3.12TCr 250.04Cr 244.56Cr 11TCr |
| Net Debt | 5.34TCr 680.29Cr 595.8Cr 548.76Cr 509.38Cr 967.29Cr 65TCr 980.37Cr 6.57TCr 2.56TCr 32TCr 2.55TCr 2.5TCr 1,10400Cr | 4.8TCr 611.53Cr 535.58Cr 493.3Cr 457.89Cr 869.51Cr 58TCr 881.27Cr 5.9TCr 2.3TCr 29TCr 2.3TCr 2.25TCr 99TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | HK$4.470 | -2.19% | 12,25,100 |
| 06/26/06 | HK$4.570 | +1.56% | 1,14,87,000 |
| 03/26/03 | HK$4.500 | +2.97% | 89,13,000 |
| 02/26/02 | HK$4.370 | +3.07% | 1,00,79,500 |
| 30/26/30 | HK$4.240 | -3.85% | 1,35,18,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
